Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Treatment of gum defects using hyaluronic acid and polynucleotides

Official title: Characterizing the Healing of Periodontal Supra-bony Defects Treated With Hyaluronic Acid and Polynucleotides

Run by Queen Mary University of London · NCT06309719 · Data updated 2026-11-12

This study is testing if adding a special gel to gum surgery helps people with gum disease heal better and faster.

More Periodontal Diseases trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorQueen Mary University of London
Academic / other
Locations2 sites (London and 1 other locations)
StatusRecruiting
StartedOctober 21, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJuly 2, 2026
Trial IDNCT06309719 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are systemically healthy adults aged 18 and older with stage III or IV periodontitis and supra-bony defects.

Probably not a fit

Patients with less severe periodontal conditions or those who have not completed prior non-surgical periodontal treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to investigate the early molecular events in wound healing and the vascularization patterns associated with treating supra-bony defects in periodontitis patients. Participants will undergo a parallel-group intervention involving either a periodontal access flap alone or in combination with a gel formulation of hyaluronic acid and polydeoxyribonucleotides. The study will involve up to 24 patients over a minimum period of 4 months, with a total of 7 visits to assess the outcomes. The research is being conducted at the Centre for Oral Clinical Research at Queen Mary University of London.

Why it matters

Potential benefit: If successful, this treatment could enhance healing and improve outcomes for patients with periodontal diseases.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in enhancing periodontal healing, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Systemically healthy males and females ≥18 years old
* Stage III or IV periodontitis (Papapanou, Sanz et al. 2018)
* Presence of supra-bony periodontal defects (i.e., defects where the base of the pocket is located coronal to the alveolar crest and characterized by a predominantly horizontal pattern of tissue destruction) confirmed clinically and radiographically at a minimum of two and a maximum of four adjacent teeth and with a probing pocket depth (PPD) \> 5 mm, following non-surgical periodontal therapy (NSPT). If \>4 adjacent teeth exhibited the above clinical and radiographic conditions, the four adjacent teeth showing the greatest overall loss of periodontal attachment were included. Wisdom teeth and second molars will not be considered for the study.

If defect presents with an intrabony component, this should be ≤2 mm.

* Non-surgical periodontal treatment (step 1 and 2) completed within the previous 4 months
* Full-mouth bleeding score (FMBS) and full-mouth plaque score (FMPS) ≤20%

Exclusion Criteria:

* Teeth with degree III mobility
* Multi-rooted teeth with grade ≥2 furcation involvement
* Heavy smokers (≥10 cigarettes a day)
* Untreated caries or endodontic lesions or abscesses on the teeth involved in the surgery
* Previous periodontal surgery in the area selected for the study
* History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures (e.g., mitral valve prolapse, artificial heart)
* Antibiotic or anticoagulant therapy during the month preceding the baseline exam.
* History of alcohol or drug abuse
* Medical history that includes uncontrolled diabetes or hepatic or renal diseases, or other serious medical conditions that can have a negative impact on the periodontal condition
* In treatment with medications that can severely affect bone metabolism and blood clot formation (e.g., anticoagulants, long-term corticosteroids, bisphosphonates, immunosuppressants)
* Self-reported pregnancy or lactation.

Where it's running

  • Barts Health NHS Trust Dental Hospital
    London, United Kingdom
    Recruiting
  • Centre for Oral Clinical Research (COCR)
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.